GATC West Virginia plays role in AI-powered analysis of new drug for liver cancer - Dominion Post

GATC West Virginia plays role in AI-powered analysis of new drug for liver cancer - Dominion Post

MORGANTOWN – GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development – an analysis that saved inestimable […] The post GATC West Virginia plays role in AI-powered analysis of new drug for liver cancer appeared first on Dominion Post.

Absci and Owkin synergise TechBio platforms to advance AI drug discovery

Absci Corporation and Owkin have announced a partnership bringing together two leading AI platforms to rapidly discover and design novel therapeutics for patients.

Developing AI-Powered Platforms for Personalized Medicine

The field of healthcare is undergoing a complete transformation driven by technological advancements, particularly in artificial intelligence (AI). Among the most promising applications of AI in healthcare is the development of AI-powered platforms for personalized medicine. These platforms are revolutionizing how diseases are diagnosed, treated, and prevented by offering tailored solutions based on individual patient data. The Need for Personal…

Data integration and its role in advancing personalized medicine

Diane Lacroix, Vice President of Clinical Data Management at eClinical Solutions, talks personalised medicine, data decisions and AI